Canterbury DHB

Context

Acute Lymphoblastic Leukaemia

This section was reviewed by Dr Peter Ganly in November 2018. The next review date is November 2021.

See a summary of changes.

In This Section

Overview

Clinical Features

Laboratory Diagnosis

Prognosis, Risk Factors and the Decision to Treat

Pre-Treatment Investigations for New ALL and Burkitt's Lymphoma Patients

Management

About this Canterbury DHB document (4398):

Document Owner:

Peter Ganly (see Who's Who)

Issue Date:

November 2018

Next Review:

November 2021

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 4398